In vitro and in vivo inhibition of the T315I mutant BCR/ABL kinase.

被引:2
|
作者
Zhu, Hong [1 ]
Hanna, Ehab [1 ]
Lohse, Dan [1 ]
Stoughton, Silva [1 ]
Tam, Betty [1 ]
Barrett, Kathy [1 ]
Noronha, Glenn [1 ]
Dneprovskaia, Elena [1 ]
Cao, Jon [1 ]
Chow, Chun [1 ]
Hwang, Linda [1 ]
Mak, Chiching [1 ]
McPherson, Andy [1 ]
Palanki, Moorthy [1 ]
Pathak, Ved P. [1 ]
Renick, Joe [1 ]
Soil, Richard [1 ]
Zeng, Binqi [1 ]
Hood, John [1 ]
机构
[1] TargeGen Inc, San Diego, CA USA
关键词
D O I
10.1182/blood.V108.11.2182.2182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2182
引用
收藏
页码:619A / 619A
页数:1
相关论文
共 50 条
  • [21] MK-0457, a novel aurora kinase and BCR-ABL inhibitor, is active against BCR-ABL T315I mutant chronic myelogenous leukemia (CML).
    Giles, Francis
    Cortes, Jorge
    Bergstrom, Donald A.
    Xiao, Alan
    Bristow, Penny
    Jones, Dan
    Verstovsek, Srdan
    Thomas, Deborah
    Kantarjian, Hagop
    Freedman, Steven J.
    BLOOD, 2006, 108 (11) : 52A - 52A
  • [22] Computer Modeling and Synthesis of Potential Inhibitors of Tyrosine Kinase BCR-ABL with the T315I Mutation
    A. N. Fedarkevich
    O. L. Sharko
    V. V. Shmanai
    Russian Journal of Bioorganic Chemistry, 2020, 46 : 187 - 198
  • [23] Computer Modeling and Synthesis of Potential Inhibitors of Tyrosine Kinase BCR-ABL with the T315I Mutation
    Fedarkevich, A. N.
    Sharko, O. L.
    Shmanai, V. V.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2020, 46 (02) : 187 - 198
  • [24] A Pyrosequencing Based Test for Quantitative Monitoring of the BCR ABL T315I Mutation
    Schumacher, J. A.
    Szankasi, P.
    Ho, A. K.
    Kelley, T. W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 869 - 869
  • [25] BGB324 Represents an Axl and BCR-ABL1 Inhibitor with Activity in the T315I Mutant
    Erdmann, Robert
    Jorgensen, Heather
    Ben-Batalla, Isabel
    Kruse, Nils
    Micklem, David
    von Amsberg, Gunhild
    Schafhausen, Philippe
    Schultze, Alexander
    Wroblewski, Mark
    Binder, Mascha
    Cubas-Cordova, Miguel
    Hadlich, Tobias
    Janning, Melanie
    Sawall, Stefanie
    Gensch, Victoria
    Allan, Elaine K.
    Mukherjee, Leena
    Morrison, Heather
    Cassells, Jennifer
    Kroeger, Nicolaus
    Lorens, James
    Clark, Richard E.
    Koschmieder, Steffen
    Vandenberghe, Peter
    Bruemmendorf, Tim H.
    Hochhaus, Andreas
    Carmeliet, Peter
    Holyoake, Tessa L.
    Pantel, Klaus
    Bokemeyer, Carsten
    Loges, Sonja
    BLOOD, 2014, 124 (21)
  • [26] Quantitative monitoring of T315I BCR-ABL mutation by the invader assay
    Kakihana, Kazuhiko
    Ohashi, Kazuteru
    Najima, Yuho
    Kikuchi, Taku
    Nagata, Yasunobu
    Ueki, Toshimitsu
    Kobayashi, Takeshi
    Yamashita, Takuya
    Akiyama, Hideki
    Yamaguchi, Toshikazu
    Sakamaki, Hisashi
    BLOOD, 2007, 110 (11) : 207B - 207B
  • [27] Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
    Afsar Ali Mian
    Anna Metodieva
    Susanne Badura
    Mamduh Khateb
    Nili Ruimi
    Yousef Najajreh
    Oliver Gerhard Ottmann
    Jamal Mahajna
    Martin Ruthardt
    BMC Cancer, 12
  • [28] Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
    Mian, Afsar Ali
    Metodieva, Anna
    Badura, Susanne
    Khateb, Mamduh
    Ruimi, Nili
    Najajreh, Yousef
    Ottmann, Oliver Gerhard
    Mahajna, Jamal
    Ruthardt, Martin
    BMC CANCER, 2012, 12
  • [29] Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036
    Chan, Wayne W.
    Wise, Scott C.
    Kaufman, Michael D.
    Ahn, Yu Mi
    Ensinger, Carol L.
    Haack, Torsten
    Hood, Molly M.
    Jones, Jennifer
    Lord, John W.
    Lu, Wei Ping
    Miller, David
    Patt, William C.
    Smith, Bryan D.
    Petillo, Peter A.
    Rutkoski, Thomas J.
    Telikepalli, Hanumaiah
    Vogeti, Lakshminarayana
    Yao, Tony
    Chun, Lawrence
    Clark, Robin
    Evangelista, Peter
    Gavrilescu, L. Cristina
    Lazarides, Katherine
    Zaleskas, Virginia M.
    Stewart, Lance J.
    Van Etten, Richard A.
    Flynn, Daniel L.
    CANCER CELL, 2011, 19 (04) : 556 - 568
  • [30] Design, Synthesis, and Biological Evaluation of Pyrazolo[3,4-d]pyrimidines Active in Vivo on the Bcr-Abl T315I Mutant
    Radi, Marco
    Tintori, Cristina
    Musumeci, Francesca
    Brullo, Chiara
    Zamperini, Claudio
    Dreassi, Elena
    Fallacara, Anna Lucia
    Vignaroli, Giulia
    Crespan, Emmanuele
    Zanoli, Samantha
    Laurenzana, Ilaria
    Filippi, Irene
    Maga, Giovanni
    Schenone, Silvia
    Angelucci, Adriano
    Botta, Maurizio
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (13) : 5382 - 5394